Biogen

Contact
biogenidec.es
+34913107110

Biogen Spain, S.L.

Paseo de la Castellana 41
28046 Madrid
Spain
+34913107110
biogenidec.es
Contact
Profile Products News
Contact

About Biogen

Our commitment to research in Multiple Sclerosis is further strengthened through the Biogen Foundation, dedicated to the promotion of training, dissemination, research and scientific development and health promotion, as well as the development of other activities that contribute To improve the living conditions of people living with neurodegenerative diseases, autoimmune disorders and hemophilia.

Read more about Biogen
Facts about Biogen
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of Biogen

Product portfolio

Show all

Similar companies

Merck Life Science KGaA

Merck Life Science KGaA

Darmstadt
Manufacturer
Laboratory analysis / Laboratory measurement technology
Biotechnology
Search companies
Merck Life Science KGaA

Merck Life Science KGaA

Darmstadt
Manufacturer
Laboratory analysis / Laboratory measurement technology
Biotechnology
Search companies

News about Biogen

Biogen

05-Jan-2021 | business & finance

ViGeneron and Biogen collaborate

ViGeneron signs global collaboration agreement for ophthalmic gene therapy development

Read news
Biogen

19-Jan-2017 | business & finance

Siemens and Biogen cooperate

Siemens Healthineers and Biogen announce agreement to jointly develop new MRI tools for multiple sclerosis

Read news
Biogen

01-Sep-2016 | science

Antibody reduces harmful brain amyloid plaques in Alzheimer's patients

Aducanumab, an antibody developed by the University of Zurich, has been shown to trigger a meaningful reduction of harmful beta-amyloid plaques in patients ...

Read news
Biogen

23-Jun-2016 | people

Biogen names executive vice president

Biogen announced the appointment of Paul McKenzie, Ph.D., as executive vice president, Pharmaceutical Operations & Technology, effective July 1, 2016. He ...

Read news
Biogen

19-Jan-2016 | business & finance

First etanercept biosimilar approved in the European Union

Biogen will manufacture and commercialize BENEPALI® in the EU

Read news
Biogen

04-Mar-2015 | research and development

Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix paediatric study

Biogen Idec and Swedish Orphan Biovitrum AB announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, ...

Read news
Biogen

28-Sep-2012 | research and development

Biogen Idec and Sobi announce positive top-line results from phase 3 study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum (Sobi)announced positive results from B-LONG, a clinical study that evaluated a new long-lasting clotting factor ...

Read news
Biogen

09-Jul-2012 | research and development

Biogen Idec and Sobi Initiate Global Clinical Trials of Long-Lasting Hemophilia A and B Product Candidates in Children

Biogen Idec and Swedish Orphan Biovitrum announced the initiation of two global pediatric clinical trials of the companies' long-lasting recombinant Factor ...

Read news
Show more news about Biogen

Here you will find Biogen Spain, S.L.